Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study

被引:16
|
作者
Zettl, Uwe K. [1 ]
Bauer-Steinhusen, Ulrike [2 ]
Glaser, Thomas [2 ]
Hechenbichler, Klaus [3 ]
Limmroth, Volker [4 ]
机构
[1] Univ Med Rostock, Klin & Poliklin Neurol, Rostock, Germany
[2] Bayer Vital GmbH, Immunol & Ophthalmol, Med Neurol, Leverkusen, Germany
[3] Inst Dr Schauerte, Oberhaching, Germany
[4] Stadt Klinikum Koln Merheim, Klin Neurol, Cologne, Germany
来源
BMC NEUROLOGY | 2013年 / 13卷
关键词
Adherence; Interferon beta-1b; Non-interventional study; Electronic diary; Multiple sclerosis; Immunomodulation; DEPRESSIVE SYMPTOMS; CES-D; THERAPY; POPULATION; VALIDATION; MEDICATION; IMPACT; COSTS; DRUGS; CARE;
D O I
10.1186/1471-2377-13-117
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Multiple sclerosis is a chronic, incurable, demyelinating disease that requires long-term treatment. Rates of non-adherence to prescribed therapy of up to 50% have been reported for chronic diseases. Strategies to improve treatment adherence are therefore of the utmost importance. This study will evaluate the effect of using electronic and paper diaries on treatment adherence to interferon beta-1b in patients with a first clinical isolated syndrome (CIS) or relapsing-remitting multiple sclerosis (RRMS). Here we report on the study design and results of baseline assessments. Methods: Patients were recruited into a prospective national multicenter cohort study for an observational period of 2 years. At the start of the study, patients opted to use a digital (DiD) or paper diary (PD) to document self-administered injections of interferon beta-1b. Adherence to treatment will be assessed on the dropout rate at the end of the observation period and on the regularity of injections every other day at 6-month intervals. Patient-related health outcomes will also be evaluated. Results: 700 patients with a mean age of 38.3 (SD 10.3) years and a mean duration of disease since diagnosis of 3.6 (SD 5.9) years were enrolled. 383 patients opted for the digital diary, 192 of which included an injection reminder. Significantly more male than female patients opted for the DiD. Only gender was identified as a factor influencing the decision for DiD or PD. Based on rating scales, a significantly higher proportion of women had depressive comorbidities at baseline. Conclusions: Demographic characteristics of the two cohorts were similar at baseline. More women chose a paper diary, and more had depression at baseline. These imbalances will be addressed in the analysis of the study as possible confounders influencing long-term treatment adherence in the digital and paper diary cohorts.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study
    Uwe K Zettl
    Ulrike Bauer-Steinhusen
    Thomas Glaser
    Klaus Hechenbichler
    Volker Limmroth
    BMC Neurology, 13
  • [2] Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
    Zettl, Uwe Klaus
    Bauer-Steinhusen, Ulrike
    Glaser, Thomas
    Czekalla, Joerg
    Hechenbichler, Klaus
    Limmroth, Volker
    Hecker, Michael
    ADVANCES IN THERAPY, 2016, 33 (05) : 834 - 847
  • [3] Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis - Results of the BetaPlus observational cohort study
    Pozzilli, Carlo
    Schweikert, Bernd
    Ecari, Ugo
    Oentrich, Wolfgang
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 307 (1-2) : 120 - 126
  • [4] Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
    Uwe Klaus Zettl
    Ulrike Bauer-Steinhusen
    Thomas Glaser
    Jörg Czekalla
    Klaus Hechenbichler
    Volker Limmroth
    Michael Hecker
    Advances in Therapy, 2016, 33 : 834 - 847
  • [5] Assessment of Medication Adherence Using a Medical App Among Patients With Multiple Sclerosis Treated With Interferon Beta-1b: Pilot Digital Observational Study (PROmyBETAapp)
    Limmroth, Volker
    Hechenbichler, Klaus
    Mueller, Christian
    Schuerks, Markus
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (07)
  • [6] Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study
    Kotterba, Sylvia
    Neusser, Thomas
    Norenberg, Christiane
    Bussfeld, Patrick
    Glaser, Thomas
    Doerner, Martin
    Schuerks, Markus
    BMC NEUROLOGY, 2018, 18
  • [7] Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study
    Sylvia Kotterba
    Thomas Neusser
    Christiane Norenberg
    Patrick Bussfeld
    Thomas Glaser
    Martin Dörner
    Markus Schürks
    BMC Neurology, 18
  • [8] Neutralising antibodies in patients with multiple sclerosis treated with interferon beta-1b
    Río, J
    Barberà, N
    Tintoré, M
    Brieva, L
    Montalbán, X
    MEDICINA CLINICA, 2000, 114 (05): : 169 - 170
  • [9] Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis
    Uzawa, A.
    Mori, M.
    Hayakawa, S.
    Masuda, S.
    Kuwabara, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (05) : 672 - 676
  • [10] Evaluation of clinical prognostic factors in Polish interferon beta-1b treated multiple sclerosis patients
    Pietrzak, Anna
    Kalinowska-Lyszczarz, Alicja
    Kozubski, Wojciech
    Michalak, Slawomir
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2019, 53 (06) : 458 - 465